lynhan documents

Calendar
Documents Calendar
Réactions du greffon contre l’hôte : moindres avec un anti-CCR5
Documents Réactions du greffon contre l’hôte : moindres avec un anti-CCR5
document
Documents document
Editorial: Software survey section
Documents Editorial: Software survey section
Why are neonatal patients a challenge for IV therapy?
Documents Why are neonatal patients a challenge for IV therapy?
Notice from the American Board of Thoracic Surgery
Documents Notice from the American Board of Thoracic Surgery
1179 PUBLICATION EGFR mutation in lung cancers treated by gefitinib in thailand
Documents 1179 PUBLICATION EGFR mutation in lung cancers treated by gefitinib in thailand
Abstracts
Documents Abstracts
Notice from the Editor
Documents Notice from the Editor
Correction
Documents Correction
Editor History, Forthcoming Papers
Documents Editor History, Forthcoming Papers
Liste des membres (2007)
Documents Liste des membres (2007)
Births, Marriages, and Deaths
Documents Births, Marriages, and Deaths
EPSOM COLLEGE WAR MEMORIAL
Documents EPSOM COLLEGE WAR MEMORIAL
ASSOCIATION OF FELLOWS OF THE ROYAL COLLEGE OF SURGEONS
Documents ASSOCIATION OF FELLOWS OF THE ROYAL COLLEGE OF SURGEONS
Cover
Documents Cover
Abstract
Documents Abstract
A colloidal oatmeal OTC cream is as clinically effective as a prescription barrier repair cream for the management of mild to moderate atopic dermatitis in African American children
Documents A colloidal oatmeal OTC cream is as clinically effective as a prescription barrier repair cream for the management of mild to moderate atopic dermatitis in African American children
Clinical Lecture ON THE TREATMENT OF ACUTE RHEUMATISM
Documents Clinical Lecture ON THE TREATMENT OF ACUTE RHEUMATISM
New Japanese method for killing dolphins is inhumane
Documents New Japanese method for killing dolphins is inhumane
Phase II trial of dose intensive chemotherapy with cisplatin, vincristine, doxorubicin and etposide (Tokushima-CODE; T-CODE) against small cell lung cancer (SCLC)
Documents Phase II trial of dose intensive chemotherapy with cisplatin, vincristine, doxorubicin and etposide (Tokushima-CODE; T-CODE) against small cell lung cancer (SCLC)